Purdue Pharma LP’s years-in-the-making bankruptcy plan and multibillion-dollar settlement with the drugmaker’s Sackler family ...
A U.S. Bankruptcy Court judge is set to give his reasoning Tuesday for approving OxyContin maker Purdue Pharma’s plan to ...
Purdue Pharma said Friday that the U.S. Bankruptcy Court for the Southern District of New York has indicated it intends to ...
Most of the money is to go to government entities to fight the opioid crisis and thousands of victims will be paid.
The $7.4 billion settlement plan of OxyContin maker Purdue Pharma was approved Tuesday by a bankruptcy court judge, a ...
Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer ...
The move comes after a bankrupcy judge said he would approve a restructuring plan for the drug maker that includes a $7.4 billion settlement ...
Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of ...
The United States Bankruptcy Court for the Southern District of New York (the "Bankruptcy Court") today indicated it will approve the Chapter 11 Plan of Reorganization (The "Plan") for Purdue Pharma L ...
Purdue Pharma’s bankruptcy plan was approved by a federal judge Sept. 1, meaning the company that made and marketed the opioid Oxycontin will be dissolved, The New York Times reported. Judge Robert ...
A majority of Purdue Pharma’s more than 120,000 creditors have voted to approve the company’s bankruptcy plan, The New York Times reported July 27. Ninety-five percent of cities, states, tribes, ...
OxyContin maker Purdue Pharma urged a bankruptcy judge on Wednesday to approve a restructuring plan that includes a $7.4 ...